Study Population and Inclusion and Exclusion Criteria
coagulation deficit, iliac lymphoma, malignant hemopathy, thrombocytopenia
ONCOLOGY, THROMBOCYTOPENIA
Eligible patients were aged 18 years and older with previously documented or suspected untreated malignant hemopathy with an indication for a bone marrow biopsy. An Eastern Cooperative Oncology Group (ECOG) performance status between 0 and 2 and normal biological coagulation parameters were required. Clinical examination and bone pelvic imaging were performed before inclusion to exclude iliac lymphoma localization. The exclusion criteria were pregnancy, congenital or acquired coagulation deficit, thrombocytopenia less than 50,000/mm